PlainDoctor

2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1659464550 M.D., PH.D
Verify on CMS →

Charles Soparkar, M.D., PH.D

Ophthalmic Plastic and Reconstructive Surgery Physician in Houston, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 303 in Ophthalmic Plastic and Reconstructive Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 293 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 642
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 84 pts below national avg 83.5 · Penalty band
Industry payments
$795.55
15 payments · CMS Open Payments (Sunshine Act)
Verify NPI on CMS Methodology
Compiled from official public sources by the editorial process.

What the federal data shows

Charles Soparkar, M.D., PH.D reported a CMS MIPS final score of 0/100 - below the 83.5 national average - and filed 1,024 Medicare Part D claims in 2024.

0/100
MIPS score · -83 vs avg
1K
Part D claims, 2024
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Charles Soparkar, M.D., PH.D

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1659464550), first enumerated 10/02/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 1,024 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 0/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Industry payment transparency

    $795.55 in reported industry payments (15 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Charles Soparkar, M.D., PH.D's individual license status. Verify directly with the state medical board.

    Source: TMB annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

Compare Soparkar with other Ophthalmic Plastic and Reconstructive Surgery Physician providers

Same primary specialty, same federal CMS NPPES roster.

Also enrolled in Texas

Other specialties in Houston: Student in an Organized Health Care Education/Training Program (4,947) · Pharmacist (2,349) · Behavior Technician (2,305) · Family Nurse Practitioner (2,271)

CMS NPPES provider registry desk

NPI 1659464550 · Ophthalmic Plastic and Reconstructive Surgery Physician

NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-LOW · RX-MID · BOOK-THIN · PHOTO-FINISH

  • NPI-10 1659464550
  • ENUM-LEGACY 2006
  • TAX-TRACE 303
  • MIPS-LOW 0/100
  • RX-MID 1,024
  • BOOK-THIN 29 in Texas
  • PHOTO-FINISH Brent Hayek, MD · ±0.0

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Charles Soparkar, M.D., PH.D's MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

0 ≥ 0th percentile 0% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). This entry sits in this band. 10–20: 3,008 measured providers (1%). Above this entry. 20–30: 3,069 measured providers (1%). Above this entry. 30–40: 2,746 measured providers (1%). Above this entry. 40–50: 2,928 measured providers (1%). Above this entry. 50–60: 5,882 measured providers (1%). Above this entry. 60–70: 13,906 measured providers (3%). Above this entry. 70–80: 94,570 measured providers (21%). Above this entry. 80–90: 129,887 measured providers (29%). Above this entry. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Charles Soparkar, M.D., PH.D sits

This provider among ophthalmic plastic and reconstructive surgery physician peers

Across the 123 ophthalmic plastic and reconstructive surgery physician providers who report both Medicare Part D prescribing and a MIPS quality score, Charles Soparkar, M.D., PH.D writes more Part D claims than 74% of them and scores higher on MIPS quality than 0% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.949.974.899.8Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 48Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 93Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 68Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 85Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 42Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 25Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 15Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 50Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 55Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 75Charles Soparkar, M.D., PH.D, Part D claim volume, percentile in specialty: 74 · MIPS quality, percentile: 0
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one ophthalmic plastic and reconstructive surgery physician peer from a representative sample of 60; the gold marker is Charles Soparkar, M.D., PH.D. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

✓
Board certification likely (heuristic, not verified)

Charles Soparkar, M.D., PH.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Charles Soparkar, M.D., PH.D?

Below national average

NPI registry status

Active

Issued 10/02/2006

NPI 1659464550

Primary specialty

Ophthalmic Plastic and Reconstructive Surgery Physician

Rare

303 US NPIs in this specialty

Medicare Part D claims

1,024 60% vs specialty avg

2024 prescription claims

Specialty avg: 642

MIPS final score

0/100 83.5 pts vs avg

Penalty band band

vs 83.5 national avg

Specialty distribution in Texas

How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician6%Student in an Organized Heal…5.3%Family Nurse Practitioner4.5%Professional Counselor4.4%Pharmacist4.3%Speech-Language Pathologist3.9%Ophthalmic Plastic and Recon…0%
Largest specialties in Texas (% of in-state providers)

Medicare quality performance, MIPS

Charles Soparkar, M.D., PH.D's 2023 MIPS final score plotted against the Ophthalmic Plastic and Reconstructive Surgery Physician national average

Below national average
MIPS Final Score
0/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%0%
MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) - 0/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

3730 KIRBY DR
Houston, TX 77098
(713) 795-0705

Provider Details

NPI 1659464550
Specialty Ophthalmic Plastic and Reconstructive Surgery Physician
Credentials M.D., PH.D
Gender Male
NPI Issued 10/02/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Measured-score avg: 83.5
0
Quality

Reporting: Individual

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Charles Soparkar, M.D., PH.D. Source: openpaymentsdata.cms.gov.

Total received

$796

Largest payer

REVANCE THERAPEUTICS, INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Charles Soparkar, M.D., PH.D. To verify Charles Soparkar, M.D., PH.D's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

Charles Soparkar, M.D., PH.D - brand share 7.0%
Ophthalmic Plastic and Reconstructive Surgery Physician average

7% brand-name claims vs 93% generic, on 1,024 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

1,024
Total Claims
$9K
Total Drug Cost
293
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,042.467
Total Day Supply
7,888
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$3K
Generic Drug Cost
$6K
Opioid Claims
121 (11.8% rate)
Antibiotic Claims
340

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
0.89
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Charles Soparkar, M.D., PH.D prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Erythromycin
Erythromycin Base
209
Cephalexin
 193
Doxycycline Monohydrate
 125
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
109
Diazepam
 98
Tramadol Hcl
 93
Methylprednisolone
 78
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
27
Promethazine Hcl
 21

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

More Ophthalmic Plastic and Reconstructive Surgery Physician in TX → All providers in Texas → Compare specialties →

Ophthalmic Plastic and Reconstructive Surgery Physician Overview

How Charles Soparkar, M.D., PH.D fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.

303
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
44
States with Ophthalmic Plastic and Reconstructive Surgery Physician
642
Avg Claims per Provider

Charles Soparkar, M.D., PH.D's 1,024 claims are above the specialty average of 642.

Nationwide Ophthalmic Plastic and Reconstructive Surgery Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Soparkar, both outside Texas so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (0 here).

Brent Hayek 0 GA Elliot Korn 0 MO Kyle Lewis 0 MS Bruce Massaro 0 WI

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Steven Laukaitis Kirkland, WA Eric Baylin Suwanee, GA Christopher Westfall Little Rock, AR Justin Johnsen Salt Lake City, UT

Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Soparkar.

One of 29 Ophthalmic Plastic and Reconstructive Surgery Physician providers enrolled in Texas, 11 are shown on this page.

Dr. David Holck
M.D.
San Antonio, TX
Dr. Donald Hollsten
MD
San Antonio, TX
Dr. Jordan Hollsten
M.D.
San Antonio, TX
Dr. Kenneth Hyde
M.D.
Houston, TX
Dr. Trevor Kerr
MD
Stephenville, TX

Compare Ophthalmic Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Charles Soparkar, M.D., PH.D's specialty? ▼
Charles Soparkar, M.D., PH.D specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in Houston, Texas. Credentials: M.D., PH.D.
How much does Charles Soparkar, M.D., PH.D prescribe under Medicare Part D? ▼
In 2024, Charles Soparkar, M.D., PH.D wrote 1,024 Medicare Part D claims totaling $9K in drug costs for 293 beneficiaries.
What is Charles Soparkar, M.D., PH.D's Medicare quality score? ▼
Charles Soparkar, M.D., PH.D has a CMS MIPS Final Score of 0/100 (Quality: 0). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Charles Soparkar, M.D., PH.D located? ▼
Charles Soparkar, M.D., PH.D is located at 3730 KIRBY DR, Houston, TX, 77098. Phone: (713) 795-0705.
What is Charles Soparkar, M.D., PH.D's NPI number? ▼
Charles Soparkar, M.D., PH.D's National Provider Identifier (NPI) is 1659464550, issued on 10/02/2006.
Does Charles Soparkar, M.D., PH.D prescribe more brand-name or generic drugs? ▼
Charles Soparkar, M.D., PH.D's prescribing is 7% brand-name and 93% generic drugs by claim count, with $3K in brand drug costs.
Does Charles Soparkar, M.D., PH.D prescribe opioids? ▼
Yes, Charles Soparkar, M.D., PH.D had 121 opioid claims in 2024 with an opioid prescribing rate of 11.8%.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US? ▼
There are 303 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 44 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 642 Medicare Part D claims per year.
What drugs does Charles Soparkar, M.D., PH.D prescribe most often? ▼
Based on 2024 Medicare Part D data, Charles Soparkar, M.D., PH.D's most frequently prescribed drugs include Erythromycin, Cephalexin, Doxycycline Monohydrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Charles Soparkar, M.D., PH.D accept Medicare? ▼
Charles Soparkar, M.D., PH.D appears in CMS Medicare data with 1,024 Part D claims and 293 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Charles Soparkar, M.D., PH.D's credentials? ▼
Charles Soparkar, M.D., PH.D's NPI is 1659464550 with credentials M.D., PH.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.